Gapping up
M&A related: PBY +6.3% (Pep Boys confirms receipt of revised, $18.50/share takeover offer from Icahn Enterprises, determines bid constitutes a superior proposal).
Select metals/mining stocks trading higher: GFI +2.6%, SBGL +2.6%, FCX +1.5% (modestly rebounding following yesterday's Chairman / co-founder news), GOLD +1.3%, AU +1.1%, GDX +0.6%.
Select oil/gas related names showing strength: SDRL +3.3%, PBR +3.2%, COG +3%, RIG +2.4%, UNG +2.4% (continued strength), WLL +2.2%, MRO +1.8%, CHK +1.7%, RDS.A +1%.
Select metals/mining stocks trading higher: GFI +2.6%, SBGL +2.6%, FCX +1.5% (modestly rebounding following yesterday's Chairman / co-founder news), GOLD +1.3%, AU +1.1%, GDX +0.6%.
Select oil/gas related names showing strength: SDRL +3.3%, PBR +3.2%, COG +3%, RIG +2.4%, UNG +2.4% (continued strength), WLL +2.2%, MRO +1.8%, CHK +1.7%, RDS.A +1%.
European names seeing strength (indices are trading broadly higher with Germany's DAX +1.5%, France's CAC +1.4%, and the U.K.'s FTSE +0.4%): NOK +1.7% and ALU +1.3%, UN +1.1%, BUD +0.9%, SAP +0.7%
European pharma names are trading higher: SHPG +2.3%, SNY +1.6%, NVS +1.4%, AZN +0.5%.
European pharma names are trading higher: SHPG +2.3%, SNY +1.6%, NVS +1.4%, AZN +0.5%.
Other news: NURO +30.4% (reports the commercial launch of DPNCheck in Mexico), ASTI +30.1% (announced that it was issued the second of two US Patents, in December, pertaining to the company's solar manufacturing process), ZN +8.4% (City of Nazareth grants approval of their exploratory drilling request from Israel's Northern District committee), RMBS +7.7% (Rambus renews patent license agreement with Toshiba for three years), FXCM +7.3% (continued strength), CMRX +5.7% (modestly rebounding despite additional analyst downgrades), ATNM +4.6% (continued strength-new multi-month highs yesterday), ADPT +3.5% (will replace Ferroglobe in the S&P SmallCap 600), PN +3.4% (recouping losses from yesterday's pullback), WSH +2.6% (to join the S&P 500), TEX +2.2% (following yesterday's ~5% decline), VRX +1.3% (The WSJ's Heard on the Street column discusses the state of affairs at Valeant (VRX) after yesterday's announcement that CEO Pearson would take a medical leave), QCOM +1.3% (signs 3G/4G Chinese patent license agreements with Haier and Beijing Tianyu Communication Equipment Co), TW +1.2% (following S&P index changes ahead of merger - Willis Group is merging with Towers Watson in a deal expected to be completed on or about that date pending final conditions), TSLA +1.2% (The WSJ highlights Tesla's hiring efforts amid increased competition. Separately, Fortune reports that Tesla will begin general production shipments of its Model X shortly), LOCK +0.6% (LifeLock discloses it entered into a Consumer Disclosure Agreement with Equifax), AMZN+0.5% (continued strength), MU +0.5% (insider purchase by CFO), AAPL +0.4% (Q4 iPhone shipments from production lines said to be 5-10% lower than originally expected, according to Digitimes), BA +0.4% (awarded a $357.8 million indefinite-delivery/indefinite-quantity contract from the Department of Defense), ADM +0.3% (Solazyme discloses warrant exchange agreement with Archer-Daniels-Midland).
Analyst comments: FANG +0.6% (remains Top Pick for 2016 at Sterne Agee CRT; Buy, $84 tgt)
Analyst comments: FANG +0.6% (remains Top Pick for 2016 at Sterne Agee CRT; Buy, $84 tgt)


